225 related articles for article (PubMed ID: 37375055)
1. The Effect of Human Milk Oligosaccharides and
Salli K; Hirvonen J; Anglenius H; Hibberd AA; Ahonen I; Saarinen MT; Maukonen J; Ouwehand AC
Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375055
[TBL] [Abstract][Full Text] [Related]
2. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
Bunesova V; Lacroix C; Schwab C
BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 2'-Fucosyllactose and
Daniels VC; Monaco MH; Wang M; Hirvonen J; Jensen HM; Ouwehand AC; Mukherjea R; Dilger RN; Donovan SM
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011074
[TBL] [Abstract][Full Text] [Related]
4. Galacto- and Fructo-oligosaccharides Utilized for Growth by Cocultures of Bifidobacterial Species Characteristic of the Infant Gut.
Sims IM; Tannock GW
Appl Environ Microbiol; 2020 May; 86(11):. PubMed ID: 32220841
[TBL] [Abstract][Full Text] [Related]
5. The effect of 2'-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose.
Salli K; Anglenius H; Hirvonen J; Hibberd AA; Ahonen I; Saarinen MT; Tiihonen K; Maukonen J; Ouwehand AC
Sci Rep; 2019 Sep; 9(1):13232. PubMed ID: 31520068
[TBL] [Abstract][Full Text] [Related]
6. Diversification of a Fucosyllactose Transporter within the Genus
Ojima MN; Asao Y; Nakajima A; Katoh T; Kitaoka M; Gotoh A; Hirose J; Urashima T; Fukiya S; Yokota A; Abou Hachem M; Sakanaka M; Katayama T
Appl Environ Microbiol; 2022 Jan; 88(2):e0143721. PubMed ID: 34731055
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
[TBL] [Abstract][Full Text] [Related]
8. In vitro fermentation of human milk oligosaccharides by individual Bifidobacterium longum-dominant infant fecal inocula.
Li H; Lane JA; Chen J; Lu Z; Wang H; Dhital S; Fu X; Huang Q; Liu F; Zhang B
Carbohydr Polym; 2022 Jul; 287():119322. PubMed ID: 35422288
[TBL] [Abstract][Full Text] [Related]
9. A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism.
Schalich KM; Buendia MA; Kaur H; Choksi YA; Washington MK; Codreanu GS; Sherrod SD; McLean JA; Peek RM; Acra SA; Townsend SD; Yan F
mBio; 2024 Apr; 15(4):e0029824. PubMed ID: 38441000
[TBL] [Abstract][Full Text] [Related]
10. Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2'-fucosyllactose.
Zabel B; Yde CC; Roos P; Marcussen J; Jensen HM; Salli K; Hirvonen J; Ouwehand AC; Morovic W
Sci Rep; 2019 May; 9(1):7983. PubMed ID: 31138818
[TBL] [Abstract][Full Text] [Related]
11. Infant Fecal Fermentations with Galacto-Oligosaccharides and 2'-Fucosyllactose Show Differential
Lindner C; Looijesteijn E; Dijck HV; Bovee-Oudenhoven I; Heerikhuisen M; Broek TJVD; Marzorati M; Triantis V; Nauta A
Children (Basel); 2023 Feb; 10(3):. PubMed ID: 36979988
[TBL] [Abstract][Full Text] [Related]
12. Genome-scale metabolic modeling of the human milk oligosaccharide utilization by
Román L; Melis-Arcos F; Pröschle T; Saa PA; Garrido D
mSystems; 2024 Mar; 9(3):e0071523. PubMed ID: 38363147
[No Abstract] [Full Text] [Related]
13. Probiotics in the New Era of Human Milk Oligosaccharides (HMOs): HMO Utilization and Beneficial Effects of
Wong CB; Huang H; Ning Y; Xiao J
Microorganisms; 2024 May; 12(5):. PubMed ID: 38792843
[TBL] [Abstract][Full Text] [Related]
14. Strain-specific strategies of 2'-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697.
Zabel BE; Gerdes S; Evans KC; Nedveck D; Singles SK; Volk B; Budinoff C
Sci Rep; 2020 Sep; 10(1):15919. PubMed ID: 32985563
[TBL] [Abstract][Full Text] [Related]
15. Preterm Infant Fecal Microbiota and Metabolite Profiles Are Modulated in a Probiotic Specific Manner.
Larke JA; Kuhn-Riordon K; Taft DH; Sohn K; Iqbal S; Underwood MA; Mills DA; Slupsky CM
J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):535-542. PubMed ID: 35881967
[TBL] [Abstract][Full Text] [Related]
16. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum.
Gotoh A; Katoh T; Sakanaka M; Ling Y; Yamada C; Asakuma S; Urashima T; Tomabechi Y; Katayama-Ikegami A; Kurihara S; Yamamoto K; Harata G; He F; Hirose J; Kitaoka M; Okuda S; Katayama T
Sci Rep; 2018 Sep; 8(1):13958. PubMed ID: 30228375
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal quantification of Bifidobacterium longum subsp. infantis reveals late colonization in the infant gut independent of maternal milk HMO composition.
Ennis D; Shmorak S; Jantscher-Krenn E; Yassour M
Nat Commun; 2024 Jan; 15(1):894. PubMed ID: 38291346
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome function and composition in infants from rural Kenya and association with human milk oligosaccharides.
Derrien M; Mikulic N; Uyoga MA; Chenoll E; Climent E; Howard-Varona A; Nyilima S; Stoffel NU; Karanja S; Kottler R; Stahl B; Zimmermann MB; Bourdet-Sicard R
Gut Microbes; 2023; 15(1):2178793. PubMed ID: 36794816
[TBL] [Abstract][Full Text] [Related]
19. Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of
Kong C; Akkerman R; Klostermann CE; Beukema M; Oerlemans MMP; Schols HA; de Vos P
Food Funct; 2021 Dec; 12(24):12513-12525. PubMed ID: 34811557
[TBL] [Abstract][Full Text] [Related]
20. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.
Asakuma S; Hatakeyama E; Urashima T; Yoshida E; Katayama T; Yamamoto K; Kumagai H; Ashida H; Hirose J; Kitaoka M
J Biol Chem; 2011 Oct; 286(40):34583-92. PubMed ID: 21832085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
